JPS5835962B2 - toothpaste composition - Google Patents
toothpaste compositionInfo
- Publication number
- JPS5835962B2 JPS5835962B2 JP14390978A JP14390978A JPS5835962B2 JP S5835962 B2 JPS5835962 B2 JP S5835962B2 JP 14390978 A JP14390978 A JP 14390978A JP 14390978 A JP14390978 A JP 14390978A JP S5835962 B2 JPS5835962 B2 JP S5835962B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- toothpaste
- sodium
- coloring
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title claims description 23
- 239000000606 toothpaste Substances 0.000 title claims description 23
- 229940034610 toothpaste Drugs 0.000 title claims description 23
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 36
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 24
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 claims description 20
- 239000001263 FEMA 3042 Substances 0.000 claims description 20
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 claims description 20
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 claims description 20
- 235000015523 tannic acid Nutrition 0.000 claims description 20
- 229940033123 tannic acid Drugs 0.000 claims description 20
- 229920002258 tannic acid Polymers 0.000 claims description 20
- 229960005070 ascorbic acid Drugs 0.000 claims description 12
- 235000015165 citric acid Nutrition 0.000 claims description 12
- 239000000551 dentifrice Substances 0.000 claims description 12
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims description 11
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 9
- 238000005498 polishing Methods 0.000 claims description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 6
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 5
- 150000001735 carboxylic acids Chemical class 0.000 claims description 5
- 239000011975 tartaric acid Substances 0.000 claims description 5
- 235000002906 tartaric acid Nutrition 0.000 claims description 5
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 4
- 235000010323 ascorbic acid Nutrition 0.000 claims description 4
- 239000011668 ascorbic acid Substances 0.000 claims description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 3
- 239000004310 lactic acid Substances 0.000 claims description 3
- 235000014655 lactic acid Nutrition 0.000 claims description 3
- 239000001630 malic acid Substances 0.000 claims description 3
- 235000011090 malic acid Nutrition 0.000 claims description 3
- 235000006408 oxalic acid Nutrition 0.000 claims description 3
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 1
- 229960004106 citric acid Drugs 0.000 claims 1
- 229940050410 gluconate Drugs 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 1
- 238000004040 coloring Methods 0.000 description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 239000002211 L-ascorbic acid Substances 0.000 description 8
- 235000000069 L-ascorbic acid Nutrition 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 230000000740 bleeding effect Effects 0.000 description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 6
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 description 5
- 235000010418 carrageenan Nutrition 0.000 description 5
- 239000000679 carrageenan Substances 0.000 description 5
- 229920001525 carrageenan Polymers 0.000 description 5
- 229940113118 carrageenan Drugs 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 230000002439 hemostatic effect Effects 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 5
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 5
- 235000002639 sodium chloride Nutrition 0.000 description 5
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 5
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 4
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 4
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 208000028169 periodontal disease Diseases 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 229910000393 dicalcium diphosphate Inorganic materials 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 230000001771 impaired effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- -1 sucrose fatty acid esters Chemical class 0.000 description 3
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 2
- 206010006326 Breath odour Diseases 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 2
- 108010001682 Dextranase Proteins 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 229960002684 aminocaproic acid Drugs 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 239000000174 gluconic acid Substances 0.000 description 2
- 235000012208 gluconic acid Nutrition 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 201000001245 periodontitis Diseases 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 230000008023 solidification Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 2
- 229960000401 tranexamic acid Drugs 0.000 description 2
- 150000003712 vitamin E derivatives Chemical class 0.000 description 2
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002253 Tannate Polymers 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- 235000012216 bentonite Nutrition 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 208000024693 gingival disease Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229940080314 sodium bentonite Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 description 1
- AQMNWCRSESPIJM-UHFFFAOYSA-M sodium metaphosphate Chemical compound [Na+].[O-]P(=O)=O AQMNWCRSESPIJM-UHFFFAOYSA-M 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
- 229960002799 stannous fluoride Drugs 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Description
【発明の詳細な説明】
本発明は歯磨組成物、さらに詳しくは、優れた止血効果
を有する歯磨組成物に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a dentifrice composition, and more particularly to a dentifrice composition that has excellent hemostatic effects.
一般に、歯磨は口腔内の清浄、口臭の除去、歯の美化な
どの目的と共に、虫歯や歯周疾患(代表的には歯槽膿漏
症が挙げられる)などの予防の目的にも使用されている
。In general, tooth brushing is used not only to clean the oral cavity, remove bad breath, and beautify teeth, but also to prevent cavities and periodontal diseases (typically pyorrhea). .
かかる虫歯や歯周疾患などの予防の目的に用いられる歯
磨には各種の薬効剤、例えば、虫歯の予防にはフッ素化
合物やデキストラナーゼなどが、また、歯周疾患の予防
にはヒノキチオール、アルミニウムアラントイン、リゾ
チーム、アズレン、食塩、ビタミンE誘導体、ε−アミ
ノカプロン酸やトラネキサム酸等の抗プラスミン剤など
が配合される。Toothpaste used to prevent cavities and periodontal diseases contains various medicinal agents, such as fluorine compounds and dextranase, and hinokitiol and aluminum to prevent periodontal diseases. Allantoin, lysozyme, azulene, common salt, vitamin E derivatives, and anti-plasmin agents such as ε-aminocaproic acid and tranexamic acid are included.
このうち、歯周疾患、ことに歯槽膿漏症は痛みめ自覚症
状がないまま、疾病自体は緩慢にしかし着実に進行する
疾患で、その自覚症状としては唾液が粘つく、口臭が強
くなる、歯ぐきがムズムズする、リンゴをかんだときや
ブラッシング時に出血が起こるなどが挙げられ、なかで
も出血の訴えが特に多いといわれ、この出血を防止する
ためには歯磨に薬効剤として食塩を配合することがよい
とされている。Among these, periodontal disease, especially alveolar pyorrhea, is a disease that progresses slowly but steadily without any painful or subjective symptoms.Subjective symptoms include sticky saliva, strong bad breath, and gum disease. Bleeding is said to be the most common complaint, and to prevent this bleeding, it is a good idea to add salt as a medicinal agent to your toothpaste. It is said that
しかしながら、所期の効果を発揮させるには高濃度の食
塩を配合する必要があり、そのために歯磨の味が非常に
特異的なものとなる欠点を有している。However, in order to achieve the desired effect, it is necessary to incorporate a high concentration of salt, which has the disadvantage that the toothpaste has a very specific taste.
本発明者らは、古来から出血作用を有するといわれてい
るタンニン酸に着目し、これを歯磨に安定に配合すれば
上記のような欠点のない止血効果に優れた歯磨が得られ
ると考え、鋭意研究を重ねた。The present inventors focused on tannic acid, which has been said to have a bleeding effect since ancient times, and believed that if it was stably incorporated into toothpaste, a toothpaste with excellent hemostatic effects without the above-mentioned drawbacks could be obtained, I have done extensive research.
タンニン酸は、その構造が現在でも充分解明されていな
いが、ブドウ糖の5個の水酸基とガロイル没食子酸の遊
離カルボキシル基がエステル結合したものと推定され、
フェノール性の水酸基を多数有しており、化学的にきわ
めて不安定である。The structure of tannic acid is still not fully elucidated, but it is presumed to be an ester bond between the five hydroxyl groups of glucose and the free carboxyl group of galloyl gallic acid.
It has many phenolic hydroxyl groups and is extremely chemically unstable.
そのため、タンニン酸を通常の歯磨に配合すると、歯磨
が黒色に着色し、その商品価値が全く失なわれてしまう
。Therefore, if tannic acid is added to ordinary toothpaste, the toothpaste will be colored black and its commercial value will be completely lost.
ところが、驚くべきことに、研磨基剤として通常用いら
れる炭酸カルシウムや第ニリン酸カルシウムを用いた場
合には防止できなかったこのタンニン酸による着色が、
研磨基剤としてやはり公知の水酸化アルミニウムを用い
、アスコルビン酸と特定のカルボン酸を添加することに
より充分に抑制できることが判明した。However, surprisingly, this coloring caused by tannic acid, which could not be prevented when using calcium carbonate or calcium diphosphate, which are commonly used as polishing bases,
It has been found that the problem can be sufficiently suppressed by using a well-known aluminum hydroxide as a polishing base and adding ascorbic acid and a specific carboxylic acid.
本発明はかかる知見に基いて完成されたものであり、主
研磨基剤として水酸化アルミニウムを用い、薬効剤とし
てタンニン酸、その安定化剤としてアスコルビン酸と、
クエン酸、グルコン酸、コハク酸、酒石酸、乳酸、リン
ゴ酸およびシュウ酸からなる群から選ばれるカルボン酸
を配合してなる歯磨組成物を提供するものである。The present invention was completed based on this knowledge, and uses aluminum hydroxide as the main polishing base, tannic acid as the medicinal agent, and ascorbic acid as its stabilizer.
A dentifrice composition containing a carboxylic acid selected from the group consisting of citric acid, gluconic acid, succinic acid, tartaric acid, lactic acid, malic acid and oxalic acid is provided.
本発明の歯磨組成物はタンニン酸配合による着色が充分
抑制され、かつ、食塩配合歯磨のような特異的な味を呈
することもな(、きわめて優れた止血効果を発揮する。The dentifrice composition of the present invention sufficiently suppresses discoloration due to the combination of tannic acid, does not exhibit a specific taste like dentifrices containing salt (and exhibits an extremely excellent hemostatic effect).
つぎの第1表に、タンニン酸を配合した各種の歯磨組成
物の着色およびその他の性状(絞り出し固さ、ペースト
の肌つや、固液分離)を検討した結果を示す。Table 1 below shows the results of examining the coloring and other properties (hardness of squeezing, texture of paste, solid-liquid separation) of various dentifrice compositions containing tannic acid.
用いた歯磨組成物は、後記実施例1の処方に準じ(タン
ニン酸の配合量1.0%)、つぎの第1表に示す研磨剤
、クエン酸、L−アスコルビン酸を配合して調製した。The dentifrice composition used was prepared by blending the abrasive, citric acid, and L-ascorbic acid shown in Table 1 below according to the formulation in Example 1 below (tannic acid content: 1.0%). .
第1表に示す結果は、これらの歯磨組成物を55℃に1
月間保持した後の着色およびその他の性状をつぎの方法
および基準に従って評価したものである。The results shown in Table 1 show that these dentifrice compositions were heated to 55°C for 1 hour.
The coloring and other properties after holding for a month were evaluated according to the following methods and criteria.
★★ 予め、標準サンプルで評
価規準を統一した3名の専門家パネルがそれぞれ白色の
紙の上にチューブ充填された歯磨を約15(1772絞
り出して、歯磨の着色、肌つやおよび固液の分離程度を
肉眼で評価した。★★ In advance, a panel of three experts who standardized the evaluation criteria using standard samples squeezed out approximately 15 (1772) pieces of toothpaste from a tube on a piece of white paper, and evaluated the toothpaste's coloring, skin gloss, and solid-liquid separation. The degree was evaluated visually.
また、その際、チューブからの絞り出し固さについても
評価した。At that time, the hardness of squeezing out of the tube was also evaluated.
いずれの評価も3名のパネルの多数意見に従い、着色の
評価は高忠実自然昼白色螢光灯下で行なった。All evaluations were carried out in accordance with the majority opinion of the three panelists, and the coloring evaluation was performed under high fidelity natural daylight white fluorescent light.
着色 ○:着色が充分抑制されている。Coloring ○: Coloring is sufficiently suppressed.
△:着色許容限界。△: Coloring tolerance limit.
×:着色著しい。×: Significant coloring.
その他の性状(絞り出し固さ、ペーストの肌つや、固液
分離)
○:着色以外の点では性状上特に問題はない。Other properties (hardness of squeezing, gloss of paste, solid-liquid separation) ○: There are no particular problems in terms of properties other than coloring.
△二商品としての許容限界。△Two permissible limits as a product.
×:ガス発生、固化などが起こり、商品価値が非常に損
なわれる。×: Gas generation, solidification, etc. occur, and the commercial value is greatly impaired.
第1表に示すごとく、基剤として炭酸カルシウムを用い
た場合はクエン酸およびL−アスコルビン酸を添加して
もタンニン酸による着色は全く抑制できず、さらに炭酸
ガスの発生が起り、商品価値が全くない。As shown in Table 1, when calcium carbonate is used as a base, the coloring caused by tannic acid cannot be suppressed at all even if citric acid and L-ascorbic acid are added, and carbon dioxide gas is generated, reducing the commercial value. Not at all.
また、基剤として第ニリン酸カルシウムを使用した場合
も、クエン酸およびL〜アスコルビン酸の濃度が比較的
高いときはある程度着色が抑制されるが、固化などが起
り、やはり商品としては適さない。Also, when calcium diphosphate is used as a base, coloring can be suppressed to some extent when the concentrations of citric acid and L-ascorbic acid are relatively high, but solidification etc. occur, making it unsuitable as a commercial product.
これに対し、基剤として水酸化アルミニウムを用いた場
合はクエン酸およびL−アスコルビン酸の添加によりタ
ンニン酸による着色が充分抑制され、商品価値も損なわ
れない。On the other hand, when aluminum hydroxide is used as the base, coloring caused by tannic acid is sufficiently suppressed by adding citric acid and L-ascorbic acid, and the commercial value is not impaired.
また、他のカルボン酸を用いて同様に検討した結果を第
2表に示す。Further, Table 2 shows the results of similar studies using other carboxylic acids.
この結果に示すごと(、クエン酸以外のカルボン酸もク
エン酸と同様な効果を示す。As shown in these results, carboxylic acids other than citric acid also exhibit similar effects to citric acid.
かくして、本発明の歯磨組成物においては主研磨基剤と
して水酸化アルミニウムを配合する。Thus, in the dentifrice composition of the present invention, aluminum hydroxide is blended as the main polishing base.
用いる水酸化アルミニウムは通常、研磨基剤として用い
られるものいずれでもよく、その配合割合も通常採用さ
れる程度でよく、例えば、平均粒経0.5〜50ミクロ
ンのものを30〜60%(重量%、以下同じ)配合する
。The aluminum hydroxide to be used may be any of those commonly used as polishing bases, and its blending ratio may be at the level normally employed. %, hereinafter the same).
なお、本発明においては研磨基剤として炭酸カルシウム
、第ニリン酸カルシウム以外の研磨基剤、例えば、無水
ケイ酸、ピロリン酸カルシウム、不溶性メタリン酸ナト
リウム、ケイ酸塩、プラスチック粉末などを水酸化アル
ミニウムと併用して研磨力の調整を行なってもよい。In the present invention, polishing bases other than calcium carbonate and calcium diphosphate, such as silicic anhydride, calcium pyrophosphate, insoluble sodium metaphosphate, silicate, and plastic powder, are used in combination with aluminum hydroxide. The polishing force may be adjusted by
タンニン酸としては五倍子または没食子から得られる一
般に使用されるものでよくその配合割合は所望の効果に
応じて適宜選択できるが、通常、組成物全量に対して0
.5〜2.0%配合することが好ましい。As tannic acid, commonly used tannic acid obtained from pentagrams or gallic acid may be used, and its blending ratio can be selected as appropriate depending on the desired effect, but it is usually 0% based on the total amount of the composition.
.. It is preferable to mix 5 to 2.0%.
アスコルビン酸は通常、組成物全量に対して0.05〜
0,5%配合することが好ましい。Ascorbic acid is usually 0.05 to 0.05 to the total amount of the composition.
It is preferable to mix 0.5%.
0.5%以上配合するとかえって着色を生じる場合があ
る。If it is blended in an amount of 0.5% or more, coloring may occur instead.
また、カルボン酸としては、前記のごとく、クエン酸、
グルコン酸、コハク酸、酒石酸、乳酸、リンゴ酸および
シュウ酸が挙げられ、これらは単独で、または2種以上
併用して配合することができる。In addition, as carboxylic acids, as mentioned above, citric acid,
Examples include gluconic acid, succinic acid, tartaric acid, lactic acid, malic acid, and oxalic acid, and these can be used alone or in combination of two or more.
その配合割合も選宜選択できるが、通常、組成物全量に
対して0.05〜1.0%配合される。Although the blending ratio can be selected as desired, it is usually blended in an amount of 0.05 to 1.0% based on the total amount of the composition.
多量に配合すると組成物のpHが低下し、配合成分の1
つである粘結剤が分解し、組成物の安定性が損なわれや
すくなるなどの点から上記の配合割合とすることが好ま
しい。If a large amount is added, the pH of the composition will decrease, and one of the ingredients
It is preferable to use the above-mentioned blending ratio in view of the fact that the binder, which is the main component, is likely to decompose and the stability of the composition is likely to be impaired.
本発明の歯磨組成物は常法に従って、練歯磨、粉歯磨、
液状歯磨などの剤形とすることができる。The dentifrice composition of the present invention can be prepared as toothpaste, powdered toothpaste, or
It can be in a dosage form such as a liquid toothpaste.
他の配合成分は通常これらに配合されるものでよく、グ
リセリン、ソルビ)−/1などの湿潤剤、ラウリル硫酸
ナトリウム、アシルサルコシンナトリウム、ショ糖脂肪
酸エステルなどの発泡剤、カルボキシメチルセルロース
ナトリウム、カラギーナン、アルギン酸ナトリウム、ベ
ントナイトなどの粘結剤、甘味料、香料などが配合され
る。Other ingredients may be those normally added to these ingredients, such as wetting agents such as glycerin and Sorbi-/1, foaming agents such as sodium lauryl sulfate, sodium acylsarcosine, and sucrose fatty acid esters, sodium carboxymethyl cellulose, carrageenan, Contains binders such as sodium alginate and bentonite, sweeteners, and flavoring agents.
また、本発明の歯磨組成物には、さらに、モノフルオロ
リン酸ナトリウム、フッ化第−錫、ε−アミノカプロン
酸、アルミニウムアラントイネート、クロルヘキシジン
、食塩、トラネキサム酸、ビタミンE誘導体、葉緑素、
デキストラナーゼ、ポリビニルピロリドン、などの薬効
剤を配合してもよい。The dentifrice composition of the present invention further includes sodium monofluorophosphate, stannous fluoride, ε-aminocaproic acid, aluminum allantoinate, chlorhexidine, salt, tranexamic acid, vitamin E derivatives, chlorophyll,
Medicinal agents such as dextranase and polyvinylpyrrolidone may be added.
つぎに実施例を挙げて本発明をさらに詳しく説明する。Next, the present invention will be explained in more detail with reference to Examples.
実施例 1 つぎの処方に従い、常法によって練歯磨を得た。Example 1 Toothpaste was obtained in a conventional manner according to the following recipe.
成 分 %
水酸化アルミニウム 45.0カル
ボキシメチルセルロースナトリウム 0.5カラギー
ナン 0.5グリセリン
10.0ソルビトール
10.0水
29.1シヨ糖脂肪酸エステル
2.0ラウロイルサルコシンナトリ
ウム 0.5香料 0.8
タンニン酸 1.0サツ
カリンナトリウム 0.2クエン
酸 0.2L−アスコ
ルビン酸 0.2得られた練歯
磨を用いてつぎのようにして止血効果のテストを行なっ
た。Ingredients % Aluminum hydroxide 45.0 Sodium carboxymethyl cellulose 0.5 Carrageenan 0.5 Glycerin
10.0 Sorbitol
10.0 water
29.1 Sucrose fatty acid ester
2.0 Sodium lauroyl sarcosine 0.5 Flavoring 0.8 Tannic acid 1.0 Sodium saccharin 0.2 Citric acid 0.2 L-ascorbic acid 0.2 Using the obtained toothpaste, the hemostatic effect is as follows. conducted a test.
(1)被験者の選定
安静時においても著しい出血反応のある20〜50才の
男性20名を選出し、歯肉からの出血状態の同程度の人
が均等に含まれるように、各々、10名ずつ実験群と対
照群の2群に分けた。(1) Selection of subjects We selected 20 men between the ages of 20 and 50 who had a significant bleeding reaction even when at rest, and 10 men from each group were selected so that they would evenly include people with the same degree of bleeding from their gums. They were divided into two groups: an experimental group and a control group.
(2)出血量の測定
実験群の被験者には実施例1の練歯磨を、また、対照群
の被験者には実施例1の処方からタンニン酸を除いた練
歯磨を使用させ、特別のフラッシング指導は行なわず、
同じ歯ブラシを用いて毎食後ブラッシングを行なうよう
指示し、4週間歯みがきを続けさせた。(2) Measurement of bleeding amount Subjects in the experimental group used the toothpaste of Example 1, and subjects in the control group used a toothpaste with the formulation of Example 1 except for tannic acid, and were given special flushing instructions. do not do it,
The subjects were instructed to brush their teeth after every meal using the same toothbrush, and they continued to brush their teeth for 4 weeks.
この間、テスト開始時、1週間後、2週間後および4週
間後に各被験者にヘマーコンビステイクス(マイルス三
m社製尿検査試験紙)の試験紙1部分を30秒間なめさ
せ、容器ラベルの比色表と対比して唾液中の潜血量を測
定した。During this period, at the beginning of the test, 1 week later, 2 weeks later, and 4 weeks later, each subject was asked to lick one portion of Hemmer Combi Stakes (urinalysis test strips manufactured by Miles Samm Co.) for 30 seconds. The amount of occult blood in saliva was measured in comparison with a colorimetric table.
各被験者の潜血量をつぎの第3表に、また、その経口変
化の有意差検定の結果をつぎの第4※表に示す。The amount of occult blood for each subject is shown in Table 3 below, and the results of the significance test for oral changes are shown in Table 4* below.
なお、第3表中の数値は潜血量を一〜十十干までの各段
階に分け、−:0、±:0.5、十:1、十〜十十:1
.5、十十:2、十十〜十+十:2.5ヶ十十十:3の
点数を付与したものである。The values in Table 3 are divided into occult blood levels from 1 to 10: -: 0, ±: 0.5, 10:1, 10 to 10:1.
.. 5, 10:2, 10~10+10:2.5 points, 110:3.
第3表および第4表から明らかなごく、本発明のタンニ
ン酸配合歯磨を継続的に使用してい(と、2週間目ぐら
いから出血量が減少し、優れた止血効果が発揮される。As is clear from Tables 3 and 4, when the tannic acid-containing toothpaste of the present invention is continuously used, the amount of bleeding decreases from about 2 weeks onwards, and an excellent hemostatic effect is exhibited.
実施例 2 つぎの処方により、常法に従って練歯磨を得た。Example 2 A toothpaste was obtained according to the following recipe according to a conventional method.
成
分
%
水酸化アルミニウム
45.0
カルボキシメチルセルロースナトリウム
0.5
或 分 %
カラギーナン 0.5グリ
セリン 80ソルビトール
12.O水
286無水ケイ酸
1.5ラウリル硫酸ナトリウム
1,5香料 0.8
タンニン酸 1.0サツ
カリンナトリウム 0.1クエン
酸 0.3L−アスコ
ルビン酸 0,2実施例 3
つぎの処方により、常法に従って練歯磨を得る。Ingredients % Aluminum hydroxide 45.0 Sodium carboxymethylcellulose 0.5% Carrageenan 0.5 Glycerin 80 Sorbitol
12. O water
286 silicic anhydride
1.5 Sodium lauryl sulfate
1,5 Flavor 0.8 Tannic acid 1.0 Saccharin sodium 0.1 Citric acid 0.3 L-ascorbic acid 0,2 Example 3 A toothpaste is obtained according to the conventional method using the following formulation.
成 分 %
水酸化アルミニウム 50.0カ
ルボキシメチルセルロースナトリウム 0.6カラギ
ーナン 0.4グリセリン
130ツルビート
7,0水
22.7無水ケイ酸
1.5シヨ糖脂肪酸エステル
1.8ラウロイルサルコシンナトリウ
ム 0.5**
成
分
香料
タンニン酸
サッカリンナトリウム
di−酒石酸
L−アスコルビン酸
%
0.7
1.0
0.1
0.4
0.3
実施例 4
つぎの処方により、常法に従って練歯磨を得る。Ingredients % Aluminum hydroxide 50.0 Sodium carboxymethyl cellulose 0.6 Carrageenan 0.4 Glycerin
130 vine beet
7,0 water
22.7 Silicic anhydride
1.5 sucrose fatty acid ester
1.8 Sodium lauroyl sarcosinate 0.5** Ingredients Flavoring Sodium saccharin tannate di-L-tartrate L-Ascorbic acid % 0.7 1.0 0.1 0.4 0.3 Example 4 According to the following recipe, according to the conventional method Get toothpaste.
成 分 %
水酸化アルミニウム 50.0カ
ルボキシメチルセルロースナトリウム 0.6カラギ
ーナン 0.4グリセリン
13.0ソルビトール
7.0水
24.9ラウリル硫酸ナトリウ
ム 1.5香料 0.
9
タンニン酸 1.0サツ
カリンナトリウム 0.1di−
酒石酸 0.4L−アスコ
ルビン酸 0.2実施例1の処
方において、タンニン酸の濃度をかえて得られた練歯磨
の香味評価を5名の専門家パネルで行なった結果を第5
表に示す。Ingredients % Aluminum hydroxide 50.0 Sodium carboxymethyl cellulose 0.6 Carrageenan 0.4 Glycerin
13.0 Sorbitol
7.0 water
24.9 Sodium lauryl sulfate 1.5 Fragrance 0.
9 Tannic acid 1.0 Satucalin sodium 0.1 di-
Tartaric acid 0.4 L-Ascorbic acid 0.2 A panel of five experts evaluated the flavor of toothpaste obtained by changing the concentration of tannic acid in the formulation of Example 1.
Shown in the table.
第5表に示すごとく、 タンニン酸の配合量が 2.0%をこえると使用が著しく悪化する。As shown in Table 5, The amount of tannic acid If it exceeds 2.0%, the usability deteriorates significantly.
Claims (1)
組成物に、タンニン酸0.5〜2.0重量%、アスコル
ビン酸0.05〜0.5重量%ならびにクエン酸、グル
コン酸、コ・・り酸、酒石酸、乳酸、リンゴ酸およびシ
ュウ酸からなる群から選ばれるカルボン酸0.05〜1
.0重量%を配合したことを特徴とする歯磨組成物。 2 該カルボン酸がクエン酸または酒石酸である前記第
1項の組成物。[Scope of Claims] 1 A dentifrice composition using aluminum hydroxide as the main polishing base contains 0.5 to 2.0% by weight of tannic acid, 0.05 to 0.5% by weight of ascorbic acid, citric acid, and gluconate. 0.05 to 1 carboxylic acid selected from the group consisting of acid, co-phosphoric acid, tartaric acid, lactic acid, malic acid and oxalic acid
.. A toothpaste composition characterized in that it contains 0% by weight. 2. The composition of item 1 above, wherein the carboxylic acid is citric acid or tartaric acid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14390978A JPS5835962B2 (en) | 1978-11-20 | 1978-11-20 | toothpaste composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14390978A JPS5835962B2 (en) | 1978-11-20 | 1978-11-20 | toothpaste composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5569508A JPS5569508A (en) | 1980-05-26 |
| JPS5835962B2 true JPS5835962B2 (en) | 1983-08-05 |
Family
ID=15349893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP14390978A Expired JPS5835962B2 (en) | 1978-11-20 | 1978-11-20 | toothpaste composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5835962B2 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5782309A (en) * | 1980-11-12 | 1982-05-22 | Irin Riyou | Dentifrice, manufacture and gargle |
| JPS62161715A (en) * | 1986-01-07 | 1987-07-17 | Kao Corp | Dentifrice agent |
| US5578294A (en) * | 1994-05-13 | 1996-11-26 | The Procter & Gamble Company | Oral compositions |
| US5560905A (en) * | 1994-05-13 | 1996-10-01 | The Proctor & Gamble Company | Oral compositions |
| US5849271A (en) * | 1995-06-07 | 1998-12-15 | The Procter & Gamble Company | Oral compositions |
| GB9513116D0 (en) * | 1995-06-28 | 1995-08-30 | Sandoz Ltd | Improvements in or relating to organic compounds |
| JP3463442B2 (en) * | 1995-12-26 | 2003-11-05 | ライオン株式会社 | Oral composition |
| US5843471A (en) * | 1997-11-06 | 1998-12-01 | Chaykin; Sterling | Oral cleansing: methods and compositions |
| EP2413884A1 (en) | 2009-04-02 | 2012-02-08 | Colgate-Palmolive Company | Exfoliating dentifrice composition and method of use |
| JP2013173730A (en) * | 2012-01-24 | 2013-09-05 | Rohto Pharmaceutical Co Ltd | Whitening composition |
| WO2018221562A1 (en) * | 2017-05-30 | 2018-12-06 | 有限会社イムノ | Composition for inhibiting production of il-8 from activated t cell |
| TR2023018280A2 (en) * | 2023-12-25 | 2024-01-22 | Bursa Uludag Ueniversitesi | A BIOACTIVE CAVITY DISINFECTANT |
-
1978
- 1978-11-20 JP JP14390978A patent/JPS5835962B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5569508A (en) | 1980-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2549979C2 (en) | Composition and method of increasing fluoride absorption with application of bioactive glass | |
| DE69905241T2 (en) | TOOTH BLEACH | |
| JPH013112A (en) | Aqueous hydrogen peroxide dental gel | |
| CA1269331A (en) | Solid oral anticariogenic composition | |
| JPS5835962B2 (en) | toothpaste composition | |
| DE60005307T2 (en) | COMPOSITION FOR TREATING HYPERSENSITIVE TEETH CONTAINING TIN FLUORIDE | |
| US4853213A (en) | Use of periwinkle in oral hygiene | |
| JPH01160911A (en) | Composition for oral cavity | |
| US4415550A (en) | Treatment-and-prophylactic tooth paste possessing anticarious effect | |
| US4436720A (en) | Granulated treatment-and-prophylactic dental preparation possessing anticarious effect | |
| RU2457829C2 (en) | Mineral and vitamin complex for strengthening tooth enamel, composition for oral cavity hygiene and toothpaste | |
| JP4730991B2 (en) | Oral composition | |
| WO2002067883A1 (en) | Cleansing compositions for oral cavity | |
| JPH1171253A (en) | Salivary secretion promoter and oral composition | |
| EP0976380B1 (en) | Method of recalcifying teeth | |
| JPH01299213A (en) | Gum washing composition and method | |
| JPS61186307A (en) | Composition for oral cavity | |
| JPH09175963A (en) | Toothpaste composition | |
| JP3690442B2 (en) | Salivary secretion promoter, oral composition and denture stabilizer | |
| RU2113842C1 (en) | Tooth paste | |
| Schaeken et al. | Control of calculus formation by a dentifrice containing calcium lactate | |
| JPH06219930A (en) | Composition for oral cavity | |
| JP3793625B2 (en) | Powder dentifrice composition | |
| JPS61186308A (en) | Composition for oral cavity | |
| RU2012329C1 (en) | Dental paste |